Report Detail

Request for Sample of this report

Other Global Cell Line Development for Biologics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4535320
    • |
  • 09 June, 2023
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Cell Line Development for Biologics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cell line development is a critical step in the production of biologics. Biologics are complex molecules that are produced by living cells, such as proteins, antibodies, and vaccines. To produce biologics in large quantities, scientists need to develop cell lines that can produce these molecules consistently and at high levels.
This report is a detailed and comprehensive analysis for global Cell Line Development for Biologics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell Line Development for Biologics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell Line Development for Biologics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell Line Development for Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell Line Development for Biologics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Line Development for Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Line Development for Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Corning, Sartorius, Thermo Fisher Scientific and Selexis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Line Development for Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CHO Cell Lines
HEK293 Cell Lines
Insect Cell Lines
Market segment by Application
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Market segment by players, this report covers
Lonza
Corning
Sartorius
Thermo Fisher Scientific
Selexis
Beckman Coulter (Danaher )
CYTENA
Molecular Devices
Samsung Biologics
Hera BioLabs
GTP Bioways
Abzena
FyoniBio
Catalent
WuXi Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Line Development for Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Line Development for Biologics, with revenue, gross margin and global market share of Cell Line Development for Biologics from 2018 to 2023.
Chapter 3, the Cell Line Development for Biologics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell Line Development for Biologics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Line Development for Biologics.
Chapter 13, to describe Cell Line Development for Biologics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cell Line Development for Biologics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell Line Development for Biologics by Type
    • 1.3.1 Overview: Global Cell Line Development for Biologics Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cell Line Development for Biologics Consumption Value Market Share by Type in 2022
    • 1.3.3 CHO Cell Lines
    • 1.3.4 HEK293 Cell Lines
    • 1.3.5 Insect Cell Lines
  • 1.4 Global Cell Line Development for Biologics Market by Application
    • 1.4.1 Overview: Global Cell Line Development for Biologics Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Monoclonal Antibodies
    • 1.4.3 Recombinant Proteins
    • 1.4.4 Vaccines
  • 1.5 Global Cell Line Development for Biologics Market Size & Forecast
  • 1.6 Global Cell Line Development for Biologics Market Size and Forecast by Region
    • 1.6.1 Global Cell Line Development for Biologics Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cell Line Development for Biologics Market Size by Region, (2018-2029)
    • 1.6.3 North America Cell Line Development for Biologics Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cell Line Development for Biologics Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cell Line Development for Biologics Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cell Line Development for Biologics Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cell Line Development for Biologics Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Lonza
    • 2.1.1 Lonza Details
    • 2.1.2 Lonza Major Business
    • 2.1.3 Lonza Cell Line Development for Biologics Product and Solutions
    • 2.1.4 Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Lonza Recent Developments and Future Plans
  • 2.2 Corning
    • 2.2.1 Corning Details
    • 2.2.2 Corning Major Business
    • 2.2.3 Corning Cell Line Development for Biologics Product and Solutions
    • 2.2.4 Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Corning Recent Developments and Future Plans
  • 2.3 Sartorius
    • 2.3.1 Sartorius Details
    • 2.3.2 Sartorius Major Business
    • 2.3.3 Sartorius Cell Line Development for Biologics Product and Solutions
    • 2.3.4 Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Sartorius Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Selexis
    • 2.5.1 Selexis Details
    • 2.5.2 Selexis Major Business
    • 2.5.3 Selexis Cell Line Development for Biologics Product and Solutions
    • 2.5.4 Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Selexis Recent Developments and Future Plans
  • 2.6 Beckman Coulter (Danaher )
    • 2.6.1 Beckman Coulter (Danaher ) Details
    • 2.6.2 Beckman Coulter (Danaher ) Major Business
    • 2.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Product and Solutions
    • 2.6.4 Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Beckman Coulter (Danaher ) Recent Developments and Future Plans
  • 2.7 CYTENA
    • 2.7.1 CYTENA Details
    • 2.7.2 CYTENA Major Business
    • 2.7.3 CYTENA Cell Line Development for Biologics Product and Solutions
    • 2.7.4 CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 CYTENA Recent Developments and Future Plans
  • 2.8 Molecular Devices
    • 2.8.1 Molecular Devices Details
    • 2.8.2 Molecular Devices Major Business
    • 2.8.3 Molecular Devices Cell Line Development for Biologics Product and Solutions
    • 2.8.4 Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Molecular Devices Recent Developments and Future Plans
  • 2.9 Samsung Biologics
    • 2.9.1 Samsung Biologics Details
    • 2.9.2 Samsung Biologics Major Business
    • 2.9.3 Samsung Biologics Cell Line Development for Biologics Product and Solutions
    • 2.9.4 Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Samsung Biologics Recent Developments and Future Plans
  • 2.10 Hera BioLabs
    • 2.10.1 Hera BioLabs Details
    • 2.10.2 Hera BioLabs Major Business
    • 2.10.3 Hera BioLabs Cell Line Development for Biologics Product and Solutions
    • 2.10.4 Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Hera BioLabs Recent Developments and Future Plans
  • 2.11 GTP Bioways
    • 2.11.1 GTP Bioways Details
    • 2.11.2 GTP Bioways Major Business
    • 2.11.3 GTP Bioways Cell Line Development for Biologics Product and Solutions
    • 2.11.4 GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 GTP Bioways Recent Developments and Future Plans
  • 2.12 Abzena
    • 2.12.1 Abzena Details
    • 2.12.2 Abzena Major Business
    • 2.12.3 Abzena Cell Line Development for Biologics Product and Solutions
    • 2.12.4 Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Abzena Recent Developments and Future Plans
  • 2.13 FyoniBio
    • 2.13.1 FyoniBio Details
    • 2.13.2 FyoniBio Major Business
    • 2.13.3 FyoniBio Cell Line Development for Biologics Product and Solutions
    • 2.13.4 FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 FyoniBio Recent Developments and Future Plans
  • 2.14 Catalent
    • 2.14.1 Catalent Details
    • 2.14.2 Catalent Major Business
    • 2.14.3 Catalent Cell Line Development for Biologics Product and Solutions
    • 2.14.4 Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Catalent Recent Developments and Future Plans
  • 2.15 WuXi Biologics
    • 2.15.1 WuXi Biologics Details
    • 2.15.2 WuXi Biologics Major Business
    • 2.15.3 WuXi Biologics Cell Line Development for Biologics Product and Solutions
    • 2.15.4 WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 WuXi Biologics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell Line Development for Biologics Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cell Line Development for Biologics by Company Revenue
    • 3.2.2 Top 3 Cell Line Development for Biologics Players Market Share in 2022
    • 3.2.3 Top 6 Cell Line Development for Biologics Players Market Share in 2022
  • 3.3 Cell Line Development for Biologics Market: Overall Company Footprint Analysis
    • 3.3.1 Cell Line Development for Biologics Market: Region Footprint
    • 3.3.2 Cell Line Development for Biologics Market: Company Product Type Footprint
    • 3.3.3 Cell Line Development for Biologics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell Line Development for Biologics Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cell Line Development for Biologics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cell Line Development for Biologics Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cell Line Development for Biologics Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cell Line Development for Biologics Consumption Value by Type (2018-2029)
  • 6.2 North America Cell Line Development for Biologics Consumption Value by Application (2018-2029)
  • 6.3 North America Cell Line Development for Biologics Market Size by Country
    • 6.3.1 North America Cell Line Development for Biologics Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cell Line Development for Biologics Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cell Line Development for Biologics Consumption Value by Type (2018-2029)
  • 7.2 Europe Cell Line Development for Biologics Consumption Value by Application (2018-2029)
  • 7.3 Europe Cell Line Development for Biologics Market Size by Country
    • 7.3.1 Europe Cell Line Development for Biologics Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 7.3.3 France Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cell Line Development for Biologics Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell Line Development for Biologics Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cell Line Development for Biologics Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cell Line Development for Biologics Market Size by Region
    • 8.3.1 Asia-Pacific Cell Line Development for Biologics Consumption Value by Region (2018-2029)
    • 8.3.2 China Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 8.3.5 India Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cell Line Development for Biologics Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cell Line Development for Biologics Consumption Value by Type (2018-2029)
  • 9.2 South America Cell Line Development for Biologics Consumption Value by Application (2018-2029)
  • 9.3 South America Cell Line Development for Biologics Market Size by Country
    • 9.3.1 South America Cell Line Development for Biologics Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cell Line Development for Biologics Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell Line Development for Biologics Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cell Line Development for Biologics Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cell Line Development for Biologics Market Size by Country
    • 10.3.1 Middle East & Africa Cell Line Development for Biologics Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cell Line Development for Biologics Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cell Line Development for Biologics Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cell Line Development for Biologics Market Drivers
  • 11.2 Cell Line Development for Biologics Market Restraints
  • 11.3 Cell Line Development for Biologics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Cell Line Development for Biologics Industry Chain
  • 12.2 Cell Line Development for Biologics Upstream Analysis
  • 12.3 Cell Line Development for Biologics Midstream Analysis
  • 12.4 Cell Line Development for Biologics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cell Line Development for Biologics. Industry analysis & Market Report on Cell Line Development for Biologics is a syndicated market report, published as Global Cell Line Development for Biologics Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cell Line Development for Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,257.28
    		4,885.92
    		6,514.56
    		547,682.40
    		821,523.60
    		1,095,364.80
    		290,545.20
    		435,817.80
    		581,090.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo